Onderzoeker
François Richard
- Disciplines:Analyse van next-generation sequence data, Bio-informatica van ziekten, Computationele transcriptomics en epigenomics, Single-cell data analyse, Gynaecologie, Immunogenetica, Inflammatie, Aangeboren immuniteit, Lipiden, Medische genomics, Medische lipidomics, Medische transcriptomics, Kankerdiagnose, Kankertherapie
Affiliaties
- Laboratorium voor Translationeel Borstkankeronderzoek (Afdeling)
Lid
Vanaf1 mrt 2019 → Heden
Projecten
1 - 2 of 2
- Moleculaire karakterisering van de tumormicro-omgeving van borstkankermetastasenVanaf11 okt 2021 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- LIQUIDEVO:Het ontrafelen van borstkanker heterogeniteit, progressie en therapierespons via analyse van stalen uit een post-mortem weefseldonatieprogramma, gebruik makende van fylogenetische reconstructiealgoritmes en een open science aanpakVanaf1 okt 2021 → HedenFinanciering: FWO senior postdoctoraal mandaat
Publicaties
11 - 20 van 56
- MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer(2023)
Auteurs: François Richard, Christine Desmedt
- Obesity-associated changes in molecular biology of primary breast cancer(2023)
Auteurs: Ha Linh Nguyen, Tatjana Geukens, Maxim De Schepper, Stefan Naulaerts, Ines Nevelsteen, Patrick Neven, Karen Van Baelen, Hanne Vos, Hans Wildiers, Beppe Floris, et al.
- Prognostic and predictive impact of beta-2 adrenergic receptor expression in HER2-positive breast cancer (vol 20, pg 262, 2020)(2023)
Auteurs: François Richard
Pagina's: E281 - E284 - Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer(2023)
Auteurs: Tatjana Geukens, Maxim De Schepper, François Richard, Karen Van Baelen, Ha Linh Nguyen, Sophia Leduc, Anirudh Pabba, Gitte Zels, Ann Smeets, Ines Nevelsteen, et al.
Pagina's: 152 - 160 - Census of exposed aggregation-prone regions in proteomes(2023)
Auteurs: François Richard
- Relation between circulating biomarkers at diagnosis of early luminal-like breast cancer and subsequent risk of distant metastases.(2023)
Auteurs: Yentl Lambrechts, Beppe Floris, Patrick Neven, Ines Nevelsteen, François Richard, Christine Desmedt, Hans Wildiers, Sigrid Hatse
- Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target(2023)
Auteurs: François Richard, Maxim De Schepper, Sophia Leduc, Tatjana Geukens, Karen Van Baelen, Ha Linh Nguyen, Beppe Floris, Christine Desmedt
Pagina's: 476 - 480 - Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer (vol 33, pg 769, 2022)(2023)
Auteurs: François Richard, Chantal Van Ongeval, Maxim De Schepper, Ann Smeets, Hans Wildiers, Patrick Neven, Christine Desmedt
Pagina's: 326 - 326 - Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER plus ) breast cancer: a retrospective analysis of the SOLE trial(2023)
Auteurs: François Richard, Beppe Floris, Patrick Neven, Christine Desmedt
- Association of body mass index with clinicopathological features and survival in patients with primary ER+/HER2-invasive lobular breast cancer(2023)
Auteurs: Karen Van Baelen, François Richard, Maxim De Schepper, Tatjana Geukens, Hans Wildiers, Ines Nevelsteen, Beppe Floris, Patrick Neven, Christine Desmedt